Corporate Overview

Beginning more than 70 years ago, Baxter has been heavily involved in many medical breakthroughs we take for granted today: intravenous medicine, kidney dialysis, blood component therapy and haemophilia care.

Baxter is a global leader in technologies related to the blood and circulatory system. The company’s blood therapies businesses produce products that collect, separate and store blood, as well as therapeutic proteins derived from blood and their genetically engineered equivalents. Its renal products cleanse the blood. Intravenous (IV) products infuse drugs and other solutions into the blood.

Throughout its history, Baxter has capitalised on expertise in select core technologies to develop a steady stream of product innovations across businesses. Because many of these products are based on related technologies, they are produced in the same manufacturing plants. The company further leverages its expertise geographically, extending the reach of its life-saving products to patients around the world. Baxter currently operates in over 110 countries worldwide.

As a subsidiary of Baxter International Inc., Baxter Canada provides critical therapies for people with life-threatening conditions. Baxter’s bioScience, medication delivery and renal products and services are used to treat patients with some of the most challenging medical conditions including cancer, hemophilia, immune deficiencies, infectious diseases, kidney disease and trauma.
 
With approximately 800 employees, two manufacturing facilities in Alliston, Ontario and Sherbrooke, Quebec, regional offices in Vancouver and Montreal, Baxter Canada is a trusted leader in healthcare bringing critical therapies to Canadians and is dedicated to our customers' success in making life better.